Search Results - "Snyder, Deann T."

Search alternatives:

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection by Hedges, Jodi F., Snyder, Deann T., Robison, Amanda, Thompson, Macy A., Aspelin, Klara, Plewa, Jack, Baldridge, Jory, Jutila, Mark A.

    Published in Innate immunity (London, England) (01-04-2023)
    “…Stimulation of innate immunity can protect against infectious insult and could be used in combination with other therapies. Since antibiotic resistance is an…”
    Get full text
    Journal Article
  2. 2
  3. 3

    An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model by Hedges, Jodi F., Snyder, Deann T., Robison, Amanda, Grifka-Walk, Heather M., Blackwell, Karlin, Shepardson, Kelly, Kominsky, Douglas, Rynda-Apple, Agnieszka, Walcheck, Bruce, Jutila, Mark A.

    Published in Frontiers in immunology (10-06-2022)
    “…Angiotensin Converting Enzyme 2 (ACE2) is the primary cell entry receptor for SARS-CoV and SARS-CoV-2 viruses. A disintegrin and metalloproteinase 17 (ADAM17)…”
    Get full text
    Journal Article
  4. 4

    Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure by Loveday, Emma K, Hain, Kyle S, Kochetkova, Irina, Hedges, Jodi F, Robison, Amanda, Snyder, Deann T, Brumfield, Susan K, Young, Mark J, Jutila, Mark A, Chang, Connie B, Taylor, Matthew P

    Published in Viruses (26-03-2021)
    “…The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3)…”
    Get full text
    Journal Article
  5. 5

    Getting “Inside” Type I IFNs: Type I IFNs in Intracellular Bacterial Infections by Snyder, Deann T., Jutila, Mark A., Hedges, Jodi F.

    Published in Journal of immunology research (01-01-2017)
    “…Type I interferons represent a unique and complex group of cytokines, serving many purposes during innate and adaptive immunity. Discovered in the context of…”
    Get full text
    Journal Article
  6. 6

    Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination by Hedges, Jodi F., Thompson, Macy A., Snyder, Deann T., Robison, Amanda, Taylor, Matthew P., Jutila, Mark A.

    Published in Vaccines (Basel) (02-06-2021)
    “…Information concerning the development of neutralizing antibodies and their duration will be critical to establishing herd immunity for COVID-19. We sought to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression by Nemudryi, Artem, Nemudraia, Anna, Wiegand, Tanner, Nichols, Joseph, Snyder, Deann T., Hedges, Jodi F., Cicha, Calvin, Lee, Helen, Vanderwood, Karl K., Bimczok, Diane, Jutila, Mark A., Wiedenheft, Blake

    Published in Cell reports (Cambridge) (01-06-2021)
    “…Over 950,000 whole-genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been determined for viruses isolated from around the…”
    Get full text
    Journal Article
  9. 9

    Solute carrier 11A1 is expressed by innate lymphocytes and augments their activation by Hedges, Jodi F, Kimmel, Emily, Snyder, Deann T, Jerome, Maria, Jutila, Mark A

    Published in The Journal of immunology (1950) (15-04-2013)
    “…Solute carrier 11A1 (SLC11A1) is a divalent ion transporter formerly known as the natural resistance-associated macrophage protein (NRAMP1) and the Bcg/Lsh/Ity…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Oral delivery of oligomeric procyanidins in Apple Poly® enhances type I IFN responses in vivo by Snyder, Deann T., Robison, Amanda, Kemoli, Sharon, Kimmel, Emily, Holderness, Jeff, Jutila, Mark A., Hedges, Jodi F.

    Published in Journal of leukocyte biology (01-05-2014)
    “…Augmentation of responses to type I IFN following ingestion of Apple Poly® may have broad therapeutic application to enhance antiviral immunity, or suppress…”
    Get full text
    Journal Article
  12. 12

    Amphotericin B stimulates γδ T and NK cells, and enhances protection from Salmonella infection by Hedges, Jodi F, Mitchell, Angela M, Jones, Kerri, Kimmel, Emily, Ramstead, Andrew G, Snyder, Deann T, Jutila, Mark A

    Published in Innate immunity (London, England) (01-08-2015)
    “…Amphotericin B (AmB) is a commonly used antifungal drug, with well-documented effects on cellular immune responses. We determined that AmB-stimulated γδ T-cell…”
    Get more information
    Journal Article
  13. 13

    Titers, prevalence and duration of SARS-CoV-2 antibodies in two waves of a local COVID-19 outbreak by Hedges, Jodi F, Thomspon, Macy A., Snyder, Deann T., Robison, Amanda, Taylor, Matthew P., Jutila, Mark A

    Published in The Journal of immunology (1950) (01-05-2021)
    “…Information concerning the development of neutralizing antibodies and their duration will be critical to establishing herd immunity for COVID-19. We sought to…”
    Get full text
    Journal Article
  14. 14

    ADAM-17 protease promotes inflammation and mortality while decreasing viral burden in a COVID-19 mouse model by Hedges, Jodi F, Snyder, Deann T., Robison, Amanda, Walk, Heather, Havlak, Karlin, Shepardson, Kelly, Kominsky, Douglas, Rynda-Apple, Agnieszka, Walcheck, Bruce, Jutila, Mark A.

    Published in The Journal of immunology (1950) (01-05-2022)
    “…Angiotensin Converting Enzyme 2 (ACE2) is the primary cell entry receptor for SARS-CoV-1 and SARS-CoV-2 viruses. A disintegrin and metalloproteinase 17…”
    Get full text
    Journal Article
  15. 15

    Expression of human TLR4/myeloid differentiation factor 2 directs an early innate immune response associated with modest increases in bacterial burden during infection by Amanda Robison, Deann T Snyder, Kelly Christensen, Emily Kimmel, Adeline M Hajjar, Mark A Jutila, Jodi F Hedges

    Published in Innate immunity (London, England) (01-10-2019)
    “…Human TLR4 (hTLR4) and mouse TLR4 molecules respond differently to hypo-acylated LPS. The LPS of Coxiella burnetii is hypo-acylated and heavily glycosylated…”
    Get full text
    Journal Article
  16. 16

    SLC11A1 is expressed by innate lymphocytes and augments their activation1 by Hedges, Jodi F., Kimmel, Emily, Snyder, Deann T., Jerome, Maria, Jutila, Mark A.

    Published in The Journal of immunology (1950) (18-03-2013)
    “…SLC11A1 is a divalent ion transporter formerly known as the natural resistance-associated macrophage protein (NRAMP1) and the Bcg/Lsh/Ity locus. SLC11A1 was…”
    Get full text
    Journal Article